Mubadala Capital
2 portfolio companies · $4.0B tracked · Data Centers, Biotechnology
Mubadala Capital has backed innovative firms through targeted deals in high-growth sectors. StreetZero currently tracks 3 deals involving Mubadala Capital, totaling $4.0B, across Data Centers, Biotechnology, and Other Technology. Those researching companies backed by Mubadala Capital can review its activity to identify strategic investments.
The Mubadala Capital portfolio features Crusoe, Iambic Therapeutics, Inc., and Spotnana Technology, Inc. These holdings highlight the firm's emphasis on technology and life sciences opportunities. Monitoring the Mubadala Capital portfolio offers clear insights into its recent deals and portfolio composition.